Related Experiment Videos
[3H]SCH39166, a D1 dopamine receptor antagonist: binding characteristics and localization
J K Wamsley1, M E Hunt, R D McQuade
1Neuropsychiatric Research Institute, Fargo, North Dakota 58103.
Experimental Neurology
|February 1, 1991
Summary
SCH39166 is a potent and specific D1 receptor antagonist, offering greater selectivity than SCH23390. Its stability in primates facilitates in vivo studies of D1 receptor antagonism.
Area of Science:
- Pharmacology
- Neuroscience
Background:
- SCH23390 is a known D1 receptor antagonist.
- There is a need for more specific D1 receptor antagonists.
Purpose of the Study:
- To characterize the binding properties of SCH39166.
- To assess the selectivity and distribution of SCH39166 as a D1 receptor antagonist.
Main Methods:
- In vitro analysis of [3H]SCH39166 binding in rat brain tissues.
- Autoradiography to localize D1 receptor sites.
Main Results:
- SCH39166 exhibits high-affinity, saturable, and specific binding to D1 receptors.
- SCH39166 demonstrates greater selectivity for D1 receptors compared to SCH23390.
- Autoradiography confirmed specific D1 receptor distribution in key brain regions.
Conclusions:
- SCH39166 is a novel D1 receptor antagonist with enhanced specificity over SCH23390.
- The compound's stability in primates supports its utility for in vivo research.